Professor Peter Andrews
Arthur Jackson Professor of Biomedical Science
Department of Biomedical Science
The University of Sheffield
Western Bank
Sheffield S10 2TN
United Kingdom
- E Floor Alfred Denny building
- Telephone: +44 (0) 114 222 4173
- Fax: +44 (0) 114-222 2399
email: p.w.andrews@sheffield.ac.uk
Research interests
The Biology of human Embryonic Stem Cells and their Malignant counterparts from Teratocarcinomas.
Read more on research in the Andrews laboratory
Career history
Department of Biomedical Science, University of Sheffield
- Arthur Jackson Professor of Biomedical Science: 1992 - present
- Chairman of Department 1995-2003
The Wistar Institute of Anatomy and Biology, Philadelphia:
- Associate Professor: 1991 - 1992
- Assistant Professor: 1983 - 1990
- Research Associate: 1980 - 1982
- Research Investigator: 1978 - 1979
Sloan-Kettering Institute, New York:
- Research Fellow: 1976 - 1978
Institut Pasteur, Paris:
- Research Fellow: 1974 - 1975
Activities and distinctions:
- Chairman, Department of Biomedical Science, 1995 -2003.
- Co-founder and Director, Axordia Ltd., A University Spin-out Company (now a subsidiary of Pfizer).
- Co-Director, Centre for Stem Cell Biology.
- Co-ordinator of ESTOOLS, a European FP6 Integrated Project (www.estools.eu) (2006 – 2010).
Other external activities
Current:
- Editorial Boards: Journal of. Anatomy, Stem Cells, Regenerative Medicine, Handbook of Stem Cells, Stem Cell Research, Stem Cells and Development.
- 2008 Member MRC Translational Stem Cell Research Panel (July 2008 – present)
- 2007 Member SAB for Stem Cells for Safer Medicines (SC4SM), a PPP company established by the DTI and the ABPI to develop applications of human ES cells in predictive toxicology (2007 – present).
- 2011 Member, UK Stem Cell Bank Advisory Board 2011 - present
- 2002 Member, Scientific Advisory Committee, Yorkshire Cancer Research, 2002 - present
Past:
- 2010 SAB Bioprocessing Technology Institute, Biopolis, Singapore, 2010 - 2011.
- 2009 Participant in MRC delegation to California (Jan 2009); to China (May 2009)
- 2009 Memner of INSERM review committee for INSERM Unit, I-Stem, Evry, Paris. Jan 2009
- 2008 Invited Participant in UK FCO sponsored ‘Road Show on UK Human ES cell research, California, Feb 2008
- 2007 Review panel for Canadian Stem Cell Network (Sept 2007).
- 2007 Expert Review Panel for 21st Century Centre of Excellence Program, Kyoto University (Japan, June 2007)
- 2006 Member Steering Committee forUK Toxicology Initiative July 2006 – 2007
- 2006 Co-ordinated for MRC and CIRM a UK:Califironia Stem Cell meeting, to be held in the UK Nov 2006.
- 2006 Member, NIH National Stem Cell Bank, USA, 2006 - 2009
- 2006 Elected Board Member, ISSCR, March 2006 to 2009
- 2005 Member MRC Molecular Cell and Medicine Board April 2005- April 2010
- 2005 Represented MRC in meeting with California Institute Regenerative Medicine, San Francisco April 2005
- 2005 Member BBSRC Visiting Group to Review Roslin Institute 11 – 14 October, 2005
- 2004 Chairman, Finnish Academy Stem Cell Grants Panel, Sept 2004
- 2003 Member, UK Stem Cell Bank Management Committee 2003 - 2011
- 2003 Member UK Stem Cell Bank User Liaison Committee 2003 – 2008
- 2002 Invited member of ad hoc committees and discussion groups of the MRC to discuss national stem cell strategy, 2002 -2003.
Current funding
- Biotechnology and Biological Sciences Research Council (BBSRC)
- European Union
- HFSP
- Medical Research Council (MRC)
- International Stem Cell Initiative
- TSB
- UK India Education and Research Initiative (UKIERI)
- Yorkshire Cancer Research (YCR)
Recent publications
Hyka-Nouspike, N., Desmarais, J., Gokhale, P.J., Jones, M., Meuth, M., Andrews, P.W., Nouspike, T.
Deficient DNA damage response and cell cycle checkpoints lead to accumulation of point mutations in human embryonic stem cells.
Stem Cells 2012. 30:1901-1910.
Chen W, Jongkamonwiwat N, Abbas L, Eshtan SJ, Johnson SL, Kuhn S, Milo M, Thurlow JK, Andrews PW, Marcotti W, Moore HD, Rivolta MN.
Restoration of auditory evoked responses by human ES-cell-derived otic progenitors.
Nature. 2012 490: 278-282.
Lund, R.J., Nikula, T., Rahkonen, N., Närvä, E., Baker, D., Harrison, N, Andrews, P., Otonkoski, T., Lahesmaa, R.
High-Throughput Karyotyping of Human Pluripotent Stem Cells.
Stem Cell Res. 2012 9: 192 – 195.
Isasi R, Knoppers BM, Andrews PW, Bredenoord A, Colman A, Hin LE, Hull S, Kim OJ, Lomax G, Morris C, Sipp D, Stacey G, Wahlstrom J, Zeng F (International Stem Cell Forum Ethics Working Party).
Disclosure and management of research findings in stem cell research and banking: policy statement.
Regen Med. 2012 7:439-448.
Alagaratnam, S., Harrison, N., Bakken1, A.C., Hoff, A., Jones, M., Sveen, A., Moore, H.D., Andrews, P.W., Lothe, R.A., Skotheim, R.I.
Transforming pluripotency: an exon-level study of malignancy-specific transcripts in human embryonic stem and embryonal carcinoma cells.
Stem Cells and Development 2013 22: 1136 - 1146
Wongtrakoongate, P, Jones, M., Gokhale, P.J., Andrews, P.W.
STELLA Facilitates Differentiation of Germ Cell and Endodermal Lineages of Human EmbryonicStem Cells
PLoS One 2013. 8: e56893
Desmarais JA, Hoffmann MJ, Bingham G, Gagou ME, Meuth M, Andrews PW
Human Embryonic Stem Cells Fail to Activate CHK1 and Commit to Apoptosis in Response to DNA Replication Stress.
Stem Cells. 2012 Jul;30(7):1385-93. doi: 10.1002/stem.1117.
